Physician profile
Steven Berlin
NPI 1568428522
$5,300.55
in general payments reported to CMS, 2019-2025
39 companies · $97.03 in 2025
The $97.03 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,320 · 2020: $554 · 2021: $939 · 2022: $884 · 2023: $784 · 2024: $722 · 2025: $97.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,603.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,602.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $1,174.74 | 2021-2024 | Harmonic, Stratafix, Dermabond |
| Intuitive Surgical, INC. | $828.62 | 2019 | |
| Abbvie INC. | $624.33 | 2020-2023 | Lo Loestrin Fe, Orilissa, Qulipta |
| Therapeuticsmd, INC. | $361.60 | 2019-2022 | |
| Astellas Pharma US INC | $247.07 | 2021-2025 | Veozah |
| Pfizer INC. | $198.82 | 2019-2024 | |
| Coopersurgical, INC. | $189.97 | 2019-2025 | Paragard T 380a, Mara Console |
| Daiichi Sankyo INC. | $179.83 | 2020-2024 | Injectafer |
| Myovant Sciences INC. | $167.74 | 2021-2022 | |
| Exeltis, USA INC. | $125.15 | 2021-2024 | Slynd |
| Evofem Biosciences, INC. | $114.53 | 2020-2022 | |
| Millicent US INC | $97.91 | 2019-2021 | |
| Allergan, INC. | $88.53 | 2019-2020 | |
| Renovia INC | $69.19 | 2019-2020 | |
| Lilly USA, LLC | $60.93 | 2020-2021 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Berlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.